Sutro Biopharma

STRO54

Penny Stock

$3.77arrow_drop_down3.82%-$0.15

Penny Stock

STRO54

$3.77

arrow_drop_down3.82%-$0.15

Penny Stock

Performance History

Key Stats
Open	$3.89
Prev. Close	$3.92
EPS	-1.78
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$309.00M
PE Ratio	-

	LOW	HIGH
Day Range	3.76	3.94
52 Week Range	2.00	6.13

Ratios







EPS	-1.78

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Sutro Biopharma (STRO)

Sutro Biopharma Inc (STRO) is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel cancer therapeutics. The company utilizes its proprietary integrated cell-free protein synthesis platform, XpressCF, to design and manufacture next-generation antibody-drug conjugates (ADCs) and bispecific antibodies. This innovative technology enables the rapid and efficient production of highly specific and potent drug candidates. STRO's pipeline includes both preclinical and clinical-stage candidates targeting various types of cancers.

With a strong emphasis on precision medicine, Sutro Biopharma aims to address the unmet medical needs of cancer patients by developing targeted therapies that have minimal off-target effects. The company's unique approach allows for the systematic evaluation and optimization of drug candidates, leading to increased efficacy and improved safety profiles. STRO's platform also offers flexibility in antibody design, allowing for the development of personalized cancer treatments.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. William J. Newell J.D.
Headquarters: South San Francisco
Employees: 297
Exchange: NASDAQ

Keep an eye on Sutro Biopharma

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Sutro Biopharma 's (STRO) price per share?

The current price per share for Sutro Biopharma (STRO) is $3.77. The stock has seen a price change of -$0.15 recently, indicating a -3.83% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Sutro Biopharma (STRO)?

For Sutro Biopharma (STRO), the 52-week high is $6.13, which is 62.6% from the current price. The 52-week low is $2, the current price is 88.03% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Sutro Biopharma (STRO) a growth stock?

Sutro Biopharma (STRO) has shown an average price growth of 0.41% over the past three years. It has received a score of 11 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Sutro Biopharma as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Sutro Biopharma (STRO) stock price performance year to date (YTD)?

As of the latest data, Sutro Biopharma (STRO) has a year-to-date price change of -17.51%. Over the past month, the stock has experienced a price change of -18.04%. Over the last three months, the change has been 14.94%. Over the past six months, the figure is 6.2%. Looking at a longer horizon, the five-year price change stands at -64.77%.

help

Is Sutro Biopharma (STRO) a profitable company?

Sutro Biopharma (STRO) has a net income of -$106.79M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -189.39% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $153.73M, although specific revenue growth data is currently not available. The gross profit is $146.92M. Operating income is noted at -$89.28M. Furthermore, the EBITDA is -$99.12M.

help

What is the market capitalization of Sutro Biopharma (STRO)?

Sutro Biopharma (STRO) has a market capitalization of $309M. The average daily trading volume is 748.1K, indicating the stock's liquidity and investor engagement.